Pfizer's stock is cheap but faces operational challenges. Analyze its valuation and performance to make informed investment ...

It sees Pfizer exit its investment in the UK consumer healthcare firm after the US group said in 2023 that it planned to ...

Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...

The ongoing investigation by Wyden and his Democratic compatriots from the Finance Committee has pointed the finger at ...

Every investor in Pfizer Inc. (NYSE:PFE) should be aware of the most powerful shareholder groups. And the group that holds ...

Pfizer will sell its remaining stake in British consumer healthcare group Haleon , the companies said on Tuesday.

Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's success in 2020 ...

Pfizer's attractive dividend yield and low P/E ratio make it appealing. Learn why PFE stock's valuation risks may be higher ...

AstraZeneca signed a deal with Alteogen worth up to $1.35 billion for subcutaneous cancer drugs. Taiho Pharmacetical bought ...

In an attempt to strike a pitch-perfect tone with Generation X, Pfizer has recruited Elizabeth Banks as the face of a new ...

In the trial, the monotherapy group demonstrated a 33% reduction in this composite ... and urgent visits for heart failure.In ...

Pfizer's vast financial resources also support ... it's worth noting that the peer-group average among dividend-paying pharma stocks currently stands at over 120%. Elevated payout ratios are ...